March 26, 2014
Toyama Chemical announced on May 24 that the Ministry of Health, Labor and Welfare (MHLW) approved its anti-influenza drug Avigan tablets 200 mg (favipiravir) on the same day. Avigan is an RNA polymerase inhibitor that prevents viral propagation by inhibiting...read more